Animal models of osteoarthritis
Related Experiment Video
Updated: Sep 30, 2026
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
1Rheumatology Division, Indiana University School of Medicine, Indianapolis, IN 46202, USA. kbrandt@iupui.edu
Abstract:
Animal models have proved to be of considerable importance in elucidating mechanisms underlying joint damage in osteoarthritis (OA) and providing proof of concept in the development of pharmacologic and biologic agents that may modify structural damage in the OA joint. The utility of animal models in predicting the response to an intervention with a drug or biologic agent in humans, however, can be established only after evidence is obtained of a positive effect of the agent in humans. To date, no agent has been shown unequivocally to have such an effect, although diacerhein and glucosamine have recently been reported to lower the rate of loss of articular cartilage in patients with hip OA and knee OA, respectively, based on measurements of the rate of joint space narrowing in plain radiographs. Furthermore, the predominant manifestation of OA - and the feature that leads people with radiographic changes of the disease to decide to seek medical attention and contributes to the enormous medicoeconomic and socioeconomic burden imposed by the disease - is joint pain. Notably, none of the animal models of OA is a good indicator of the analgesic effects of pharmacologic agents. Indeed, it should not be assumed a priori that reduction in the rate of progression of joint damage in OA will be associated with a reduction in joint pain.
Insights
Animal models aid osteoarthritis (OA) research but don't predict human pain relief. Current treatments show limited structural benefit, and pain remains a key OA symptom. Further research is needed for effective OA pain management.
Area of Science:
- Orthopedics
- Pharmacology
- Rheumatology
Background:
- Animal models are crucial for understanding osteoarthritis (OA) mechanisms and testing potential treatments.
- However, their ability to predict human responses to drugs is limited.
- Osteoarthritis significantly impacts patients through joint pain and imposes a substantial socioeconomic burden.
Purpose of the Study:
- To evaluate the utility of animal models in osteoarthritis research.
- To assess the effectiveness of current agents in modifying OA structural damage and pain.
- To highlight the limitations of animal models in predicting analgesic effects.
Main Methods:
- Review of existing literature on animal models in osteoarthritis.
- Analysis of clinical trial data for agents targeting structural damage in OA.
- Examination of the relationship between structural damage and pain in OA patients.
Main Results:
- Animal models have advanced understanding of OA joint damage and drug development.
- No agent has unequivocally demonstrated disease modification in humans.
- Diacerhein and glucosamine show potential in slowing cartilage loss in specific OA types.
- Animal models do not reliably predict the analgesic effects of pharmacologic agents.
Conclusions:
- While valuable for structural damage research, animal models have limitations in predicting OA treatment outcomes, especially pain relief.
- The dissociation between structural damage progression and pain relief necessitates further investigation.
- Developing effective OA pain management strategies requires approaches beyond current animal model assessments.